Skip to main content
Clinical Trials/CTRI/2014/09/005027
CTRI/2014/09/005027
Completed
Phase 1

Treatment of large segmental bone defects with custom made triphasic hydroxyapaptite scaffolds loaded with mesenchymal stem cells in children.

Department of Biotechnology0 sites10 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Health Condition 1: M865- Other chronic hematogenous osteomyelitisHealth Condition 2: M845- Pathological fracture in neoplastic diseaseHealth Condition 3: null- Segmental bone defects following resection of tumor, infection or trauma in children
Sponsor
Department of Biotechnology
Enrollment
10
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
November 30, 2018
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Biotechnology

Eligibility Criteria

Inclusion Criteria

  • Children over one year of age with large bone defects following tumor resection post\-traumatic bone loss, post infective bone loss or loss due to any other causes with a good intact soft tissue envelope and giving consent for the experimental treatment

Exclusion Criteria

  • i)Active infection
  • ii)Poor soft tissue cover
  • iii) Patients who are not likely to come for a full review process of 2 years
  • iv)Patients who are not likely to survive for 2 years due to their disease process

Outcomes

Primary Outcomes

Not specified

Similar Trials